Live Better & Longer With Artificial Intelligence
Monday evening marked the opening session of Live With AI, an independent think-tank initiated in Singapore that strives to guide the future of AI in a human-centered manner.
The session kicked off with anticipation-filled opening speeches from Vincenzo Esposito Vinzi, Dean & President of ESSEC Business School and Pierre Robinet, Vice-President of OgilvyRED and Live With AI Board Member. Vincenzo shared with the eager crowd his excitement in training the future generation of thought leaders to be better designers, developers, and deliverers of Artificial Intelligence (AI). Pierre then spoke about the responsibility that the digital community undertakes in imagining and innovating the solutions that will allow us to shape our common future. Following this, the panel conversation began with a discussion on the current status of healthcare. Using the effects of mental issues on physical ailments such as diabetes and cardiovascular disease as an example, Joydeep Sarkar of Holmusk highlighted the importance of a more holistic and coordinated approach to care.
Joydeep Sarkar, Chief Analytics Officer of Holmusk
Christopher Lien, Director of Community Geriatrics, Changi General Hospital
Mounir Mokthari, Director, IPAL CNRS
Jason Tamara Widjaja, Associate Director of Data Science, MSD
What makes data valuable?
Transitioning into the topic of the role of data in healthcare, Mounir Mokthari of IPAL-CNRS said “We need to accept that data may be the new Bitcoin. Data now is money”. Indeed, many companies increasingly see data as an asset and are even leveraging on it to obtain funding. It seems there is a race to collect the most data – new and innovative technologies doing so are rapidly being developed. However, Jason Widjaja of MSD stressed that the real winners are the ones not only with the most data, but also the with the most trust[worthy data]. He pointed out the inherent inequality in data quality, citing how data collected by means that are prone to mistakes and manipulation may impede the drug discovery process. However, it was optimistically noted that there has been a wave of collaboration in recent years where clinical trial data, which is collected more robustly, is being shared publicly for all to benefit. Joydeep Sarkar of Holmusk offered an interesting perspective that data is made most valuable when one manages to learn from and get insight out of it. Heaps of scattered data is rarely of practical use when presented to medical experts in raw form. The true winners are the ones who are able to contextualise the data and distill it to a level such that it becomes consumable and actionable for the individual.
A place for AI in healthcare
Hospitals have for a long time been open to the prospect of technological advancement. In fact, AI is already extensively found filling roles in the process flow and logistic support of hospitals. However, Christopher Lien of CGH very candidly expressed his reservations as to how large a role AI is able to play at the patient interface level, noting that we have a long way to go before the whole process can be automated. Speaking from the perspective of the technology companies, Joydeep acknowledged the many challenges in bringing new technology to the hospital. He added that many companies today invest much in product innovation but do not focus enough on engaging hospitals and clinics to better deliver the product.
What about outside of the hospital? At present, the data that doctors use to understand patients is collected at each hospital visit. A gap in knowledge exists – one that AI could fill by supplying the rest of the information where the patient is away from the hospital. Joydeep underlined the value of building the intelligence on sound scientific principles – not only for accuracy but also for efficacy. “What we have resorted to, knowing that we are going to play in the space where the meaningful data lies, tracking patients as they go through their journey, is to resort to methods that are more based on biology, using scientific data from literature that has been collected over the past 50 years. This way we can bring both the scientific community and clinicians onboard, telling them, we’re using the exact same information you use and processing it in the same way you do”.
To conclude the stimulating discussion, Kevyn Yong, Dean of ESSEC Business School, Asia Pacific took the stand to deliver a rousing closing address. In wrapping up the eventful evening, he left us with a simple but pertinent question: What job should AI do in healthcare? Indeed, given the rapid, multi-directional advancement of this dynamic field, there is not a straightforward answer to this. The future of AI is promising, prospects are exciting and possibilities endless.
About Live With AI
Initiated at the occasion of the 2018 Year of Innovation (following Joint Declaration on Innovation on the occasion of the State Visit by French President François Hollande to Singapore in March 2017), Live With AI (LWAI) is an independent think-tank gathering 50 thought leaders from France and Singapore, with academic, innovation, scientific, entrepreneur and business backgrounds, all believing Artificial Intelligence (AI) will positively impact our society and contribute to accelerate our human development.
— Holmusk (@holmusk) March 13, 2018
Cheryl Leong 14th March 2018
Chief Analytics Officer at Holmusk
Monday, 12 March 2018
From 1830 to 2100 (SGT)
ESSEC Business School, Singapore
EESEC Business School
5 Nepal Park,